PepsiCo (PEP) Q1 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q1 2025 earnings summary
3 Feb, 2026Executive summary
Q1 2025 net revenue was $17.9B, down 1.8% year-over-year, with operating profit at $2.6B and net income at $1.83B, both declining due to higher costs, FX headwinds, and commodity pressures.
Diluted EPS was $1.33 (down from $1.48), and core (non-GAAP) EPS was $1.48 (down 4%); operating margin declined to 14.4%.
International business remains the primary growth engine, with strong performance in India, Brazil, and Europe, but softness in China and Mexico.
Major acquisitions included Siete ($1.2B closed) and a pending $1.95B deal for poppi, supporting portfolio expansion.
Guidance for 2025 was reduced due to tariffs, macroeconomic uncertainty, and subdued FLNA performance.
Financial highlights
Q1 organic revenue growth was 1%, with international segment delivering 5% organic growth; gross profit was $9.99B, nearly flat year-over-year.
FLNA experienced a 4% volume decline, while PBNA showed margin improvement and share gains.
Free cash flow for the quarter was $(1.44)B, reflecting acquisition and capital spending.
Cash and cash equivalents at quarter-end were $8.3B; total assets $101.7B.
Dividend per share increased 5% to $5.69 annualized; $1.88B in dividends and $183M in share repurchases returned to shareholders.
Outlook and guidance
Full-year earnings outlook reduced, mainly reflecting tariffs, consumer uncertainty, and FLNA's slower recovery; core constant currency EPS now expected to be flat year-over-year.
Top-line guidance reaffirmed, supported by international momentum and scenario planning for tariffs.
Total cash returns to shareholders in 2025 expected at $8.6B (dividends $7.6B, share repurchases $1.0B).
High-inflation economies now included in organic sales growth guidance, but impact is immaterial.
Foreign exchange translation expected to be a 3 percentage point headwind to reported net revenue and core EPS growth.
Latest events from PepsiCo
- $94B revenue, health-driven innovation, and global expansion drive growth and margin targets.PEP
Consumer Analyst Group of New York Conference (CAGNY) 202618 Feb 2026 - Affordability, innovation, and strong Q4 results drive growth and higher dividends in 2026.PEP
Q4 20253 Feb 2026 - Q2 2024 delivered strong EPS and margin gains, but Quaker recall and guidance cut weighed.PEP
Q2 20243 Feb 2026 - Q3 profit fell on higher costs and recall, but core EPS and shareholder returns remain strong.PEP
Q3 202419 Jan 2026 - 2024 saw margin and EPS growth; 2025 outlook is cautious but targets continued gains and higher dividend.PEP
Q4 20249 Jan 2026 - Portfolio innovation, digitalization, and global expansion drive strong growth and future targets.PEP
Consumer Analyst Group of New York Conference (CAGNY ) 20258 Jan 2026 - Q2 2025 revenue grew 1%, but profit and EPS plunged on $1.86B–$1.9B impairments.PEP
Q2 202523 Dec 2025 - 2026 targets 2–4% organic revenue and 4–6% core EPS growth, driven by innovation and cost savings.PEP
Status Update12 Dec 2025 - Annual meeting to vote on directors, auditor, executive pay, and four shareholder proposals.PEP
Proxy Filing1 Dec 2025